Home/Filings/4/0001214659-18-003874
4//SEC Filing

Huang Kelly 4

Accession 0001214659-18-003874

CIK 0001427570other

Filed

May 16, 8:00 PM ET

Accepted

May 17, 7:19 PM ET

Size

4.8 KB

Accession

0001214659-18-003874

Insider Transaction Report

Form 4
Period: 2018-05-15
Huang Kelly
Chief Operating Officer
Transactions
  • Award

    Common Stock (Restricted Stock Award)

    2018-05-15+65,00065,000 total
Footnotes (1)
  • [F1]The Restricted Shares shall vest as to 100% of the Shares underlying the Award on January 2, 2020, subject to the reporting person's provision of service to the Issuer.

Issuer

OBALON THERAPEUTICS INC

CIK 0001427570

Entity typeother

Related Parties

1
  • filerCIK 0001602803

Filing Metadata

Form type
4
Filed
May 16, 8:00 PM ET
Accepted
May 17, 7:19 PM ET
Size
4.8 KB